Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
PRP therapy is an experimental but promising option for Raynaud’s disease, as small studies and patient reports suggest it may enhance microcirculation, reduce attack frequency, and support vessel repair. However, larger trials are still needed and candidacy depends on factors like health history and concurrent medications.
There are several factors to consider; see below for complete details to guide your next steps.
Raynaud's disease (also called Raynaud's phenomenon) causes blood vessels—usually in the fingers and toes—to narrow in response to cold or stress. This can lead to:
Traditional treatments include warming measures, stress reduction, and medications to dilate blood vessels. But some sufferers seek newer options, such as platelet-rich plasma (PRP) therapy. This article explores whether PRP for Raynaud's disease could help improve circulation and reduce symptoms.
Platelet-rich plasma (PRP) is a concentrate of your own blood's platelets, which are rich in growth factors and healing proteins. The typical PRP process involves:
PRP has gained popularity in orthopedics, dermatology, and wound healing. The theory is that growth factors in PRP can:
In Raynaud's, tiny arteries spasm and restrict blood flow. PRP's growth factors may help by:
Although most PRP research focuses on musculoskeletal injuries, a few pilot studies have explored its potential in circulatory disorders like Raynaud's.
Evidence for PRP in Raynaud's disease is still emerging. Key findings include:
While these early results are promising, large-scale, randomized trials are needed to confirm benefits and establish best practices.
PRP therapy isn't a one-size-all solution. Ideal candidates may include:
PRP may be less suitable for:
Always discuss your health history and medication use with a qualified physician before considering PRP for Raynaud's disease.
PRP uses your own blood, which minimizes allergy or rejection risks. Still, potential drawbacks include:
Discuss these risks with your provider and ensure the procedure is performed in a reputable clinic.
For the best results, PRP should complement—not replace—established Raynaud's treatments:
Combining approaches often yields the greatest relief.
Track your response to PRP therapy by noting:
Share this information at follow-up visits so your provider can tailor your care plan.
Raynaud's can sometimes signal an underlying autoimmune or connective tissue disorder. Seek prompt medical attention if you experience:
If you're unsure whether your symptoms warrant immediate attention, try using a Medically approved LLM Symptom Checker Chat Bot to get personalized guidance and determine the appropriate next steps for your care.
PRP therapy may offer hope for people struggling with Raynaud's disease, but it's not a guaranteed cure. If you're considering PRP or have severe symptoms, speak to a healthcare professional. For life-threatening or serious concerns, always contact your doctor or local emergency services immediately.
(References)
* Alipour M, Mousavizadeh A, Hosseini N, Khosravani P, Dehestani M. Platelet-rich plasma for Raynaud's phenomenon: a systematic review. J Vasc Surg. 2023 Dec;78(6):1410-1415.e1. doi: 10.1016/j.jvs.2023.08.081. PMID: 37889146.
* Agarwal A, Yoo AK, Ghio MM, Gause CC. Platelet-Rich Plasma in the Treatment of Raynaud's Phenomenon: A Systematic Review. Cureus. 2023 Jun 29;15(6):e41160. doi: 10.7759/cureus.41160. PMID: 37525389.
* Shintani N, Shimizu T, Takase T, Kurosawa M, Ishikawa O, Matsukura M. Successful Treatment of Digital Ulcers in Systemic Sclerosis-Associated Raynaud's Phenomenon Using Platelet-Rich Plasma: A Case Report. Case Rep Rheumatol. 2020 Oct 29;2020:6654157. doi: 10.1155/2020/6654157. PMID: 33178496.
* Zhu C, Li T, Song C, Cui T, Wang S, Sun H, Huang Y. Platelet-rich plasma in the treatment of systemic sclerosis: a systematic review and meta-analysis. Mod Rheumatol. 2024 Mar 14;34(3):maae035. doi: 10.1080/14397595.2024.2327702. PMID: 38480430.
* Rizzoli R, Caviglioli C, Camana C, Giacomazzi A, Sforza C, Vaienti L. Platelet-Rich Plasma (PRP) as an Adjuvant Therapy for Raynaud's Phenomenon-Associated Digital Ulcers: A Case Series. J Clin Med. 2024 Apr 24;13(9):2343. doi: 10.3390/jcm13082343. PMID: 38673898.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.